Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors

NCT06848491 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2026-03-23

No results posted yet for this study

Summary

The AYA WELL study is a 2-arm randomized clinical trial to test the efficacy of a theory-based, mHealth weight management intervention adapted specifically for adolescent and young adult cancer survivors compared to a self-guided arm. Participants, diagnosed with cancer between ages 15-39, currently age 18-39, post-treatment at least 6 months, and who have overweight or obesity will be randomized to receive either: 1) a comprehensive mHealth weight management program (intervention) or 2) digital tools + health education + peer support (self-guided) over 12 months. Outcomes will be assessed at 3, 6, and 12 months.

Conditions

Interventions

BEHAVIORAL

AYA WELL Intervention

Behavioral weight management intervention for adolescent and young adult cancer survivors with digital tools, smartphone web app behavioral program, text messages, and expert-guided closed social networking group for peer support.

BEHAVIORAL

Self-Guided

Self-guided intervention with digital tools, periodic informational support, and moderated social networking group for peer support.

Sponsors & Collaborators

  • Virginia Commonwealth University

    collaborator OTHER
  • National Cancer Institute (NCI)

    collaborator NIH
  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Carmina G. Valle, PhD, MPH · University of North Carolina, Chapel Hill

  • Jessica Gokee LaRose, PhD · Virginia Commonwealth University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-27
Primary Completion
2028-04-30
Completion
2028-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06848491 on ClinicalTrials.gov